One thousand somatic SNVs per skin fibroblast cell set baseline of mosaic mutational load with patterns that suggest proliferative origin, Genome Res, vol.27, pp.512-523, 2017. ,
, , 2017.
, Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life, Am. J. Hum. Genet, vol.101, pp.50-64
, , 2010.
, J. Pathol, vol.221, pp.49-56
Clock-like mutational processes in human somatic cells, Nat. Genet, vol.47, pp.1402-1407, 2015. ,
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy, Cancer Discov, vol.6, pp.479-491, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01872958
CancerAssociated Mutations in Endometriosis without Cancer, N. Engl. J. Med, vol.376, pp.1835-1848, 2017. ,
Next-Generation Sequencing of Circulating Tumor DNA for Early Cancer Detection, Cell, vol.168, pp.571-574, 2017. ,
Tissue-specific mutation accumulation in human adult stem cells during life, Nature, vol.538, pp.260-264, 2016. ,
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer, Nat. Rev. Cancer, vol.15, pp.668-679, 2015. ,
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin, vol.68, pp.394-424, 2018. ,
TP53 mutations, tetraploidy and homologous recombination repair defects in early stage high-grade serous ovarian cancer, Nucleic Acids Res, vol.43, pp.6945-6958, 2015. ,
The failure of protein cancer biomarkers to reach the clinic: why, and what can be done to address the problem, BMC Med, vol.10, p.87, 2012. ,
Liquid biopsies: genotyping circulating tumor DNA, J. Clin. Oncol, vol.32, pp.579-586, 2014. ,
The Yet Unrealized Promise of Ovarian Cancer Screening, JAMA Oncol, vol.4, pp.456-457, 2018. ,
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence, N. Engl. J. Med, vol.371, pp.2477-2487, 2014. ,
Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement, US Preventive Services Task Force, vol.319, pp.588-594, 2018. ,
Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force, JAMA, vol.319, pp.595-606, 2018. ,
, , 2016.
, Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing, Proc. Natl. Acad. Sci. USA, vol.113, pp.9846-9851
Age-related clonal hematopoiesis associated with adverse outcomes, N. Engl. J. Med, vol.371, pp.2488-2498, 2014. ,
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis, Proc. Natl. Acad. Sci. USA, vol.100, pp.8424-8429, 2003. ,
Detecting ultralow-frequency mutations by Duplex Sequencing, Nat. Protoc, vol.9, pp.2586-2606, 2014. ,
Evaluation of DNA from the, Cell Reports, vol.28, p.143, 2013. ,
, Papanicolaou test to detect ovarian and endometrial cancers. Sci. Transl. Med, vol.5, pp.167-171
Ultradeep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues, Proc. Natl. Acad. Sci. USA, vol.113, pp.6005-6010, 2016. ,
TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions, J. Pathol, vol.226, pp.421-426, 2012. ,
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory, Am. J. Surg. Pathol, vol.34, pp.433-443, 2010. ,
High grade serous ovarian carcinomas originate in the fallopian tube, Nat. Commun, vol.8, p.1093, 2017. ,
The landscape of somatic mutation in normal colorectal epithelial cells, 2018. ,
TP53 mutations in human cancer: database reassessment and prospects for the next decade, Hum. Mutat, vol.35, pp.672-688, 2014. ,
dbNSFP v3.0: A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs, Hum. Mutat, vol.37, pp.235-241, 2016. ,
Lavage of the Uterine Cavity for Molecular Detection of M? ullerian Duct Carcinomas: A Proof-of-Concept Study, J. Clin. Oncol, vol.33, pp.4293-4300, 2015. ,
Uterine and Tubal Lavage for Earlier Cancer Detection Using an Innovative Catheter: A Feasibility and Safety Study, Int. J. Gynecol. Cancer, vol.28, pp.1692-1698, 2018. ,
Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin, Science, vol.348, pp.880-886, 2015. ,
Somatic mutant clones colonize the human esophagus with age, Science, vol.362, pp.911-917, 2018. ,
,
, Genomic Analysis of Uterine Lavage Fluid Detects Early Endometrial Cancers and Reveals a Prevalent Landscape of Driver Mutations in Women without Histopathologic Evidence of Cancer: A Prospective Cross-Sectional Study, PLoS Med, vol.13, p.1002206
Aging and the rise of somatic cancerassociated mutations in normal tissues, PLoS Genet, vol.14, 2018. ,
Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations, Nat. Rev. Genet, vol.19, pp.269-285, 2018. ,
Detection of ultra-rare mutations by next-generation sequencing, Proc. Natl. Acad. Sci. USA, vol.109, pp.14508-14513, 2012. ,
Sequencing small genomic targets with high efficiency and extreme accuracy, Nat. Methods, vol.12, pp.423-425, 2015. ,
The Genetic Evolution of Melanoma from Precursor Lesions, N. Engl. J. Med, vol.373, pp.1926-1936, 2015. ,
, Cancer Statistics, vol.67, pp.7-30, 2017.
The fallopian tube, ''precursor escape'' and narrowing the knowledge gap to the origins of high-grade serous carcinoma, Gynecol. Oncol, vol.152, pp.426-433, 2019. ,
Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium, Cell Rep, vol.24, pp.1777-1789, 2018. ,
, Integrated genomic analyses of ovarian carcinoma, The Cancer Genome Atlas Research Network, vol.474, pp.609-615, 2011.
Seshat: A Web service for accurate annotation, validation, and analysis of TP53 variants generated by conventional and next-generation sequencing, Hum. Mutat, vol.39, pp.925-933, 2018. ,
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study, Int. J. Gynecol. Pathol, vol.35, pp.48-55, 2016. ,
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers, Sci. Transl. Med, vol.10, p.8793, 2018. ,
The origin and evolution of mutations in acute myeloid leukemia, Cell, vol.150, pp.264-278, 2012. ,
, , 2014.
, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat. Med, vol.20, pp.1472-1478
The landscape of somatic mutations in protein coding genes in apparently benign human tissues carries signatures of relaxed purifying selection, Nucleic Acids Res, vol.44, pp.2075-2084, 2016. ,
For the last 3 variables (frequency in cancer database, activity, and pathogenicity), mutations were aggregated into 5 categories and 2 categories. Categories of frequency in cancer database included very frequent, frequent, not frequent, rare/unique, and never identified in human cancer. The first 2 categories were considered ''common in cancer'' and the last 3 categories ''not common in cancer, Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat. Commun. 7, 12484. variables were used to annotate the DS pipeline-generated mutational calls in Table S3 (uterine lavage) and Table S5 (normal tissue), vol.179, 2003. ,